Lulu Jia
Guilin, 541001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Triptolide enhances lenvatinib sensitivity in hepatocellular carcinoma by regulating CERK-mediated sphingolipid-ferroptosis axis.
Journal: International immunopharmacology
Published: March 15, 2026
Celastrol Induces Ferroptosis by Regulating CERKL to Exert Anti-Gastric Cancer Effect.
Journal: The American journal of Chinese medicine
Published: May 15, 2025
Deep learning-based MRI model for predicting P53-mutated hepatocellular carcinoma.
Journal: BMC medical imaging
Published: May 12, 2025
Macrotrabecular-massive subtype in hepatocellular carcinoma based on contrast-enhanced CT: deep learning outperforms machine learning.
Journal: Insights into imaging
Published: April 11, 2025
Triptolide's impact on ACER1 signaling: Inducing autophagy for triple-negative breast cancer suppression.
Journal: Pathology, research and practice
Published: October 19, 2024
[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 09, 2022
Triptolide Inhibits the Biological Processes of HUVECs and HepG2 Cells via the Serine Palmitoyltransferase Long Chain Base Subunit 2/Sphingosine-1-Phosphate Signaling Pathway.
Journal: Disease markers
Published: July 18, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026